People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
The move expands access to the novel mental health treatment, which has shown rapid symptom improvement for the past few ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback